LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.76 | 17.25 | 9784 | 6047 | 1.6177 | 1.1171 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 88.76 | 17.25 | 11275 | 6047 | 1.8643 | 1.1529 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 90.74 | 17.25 | 10009 | 6109 | 1.6382 | 1.1200 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 90.74 | 17.25 | 11498 | 6109 | 1.8820 | 1.1551 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.71 | 17.25 | 10344 | 6184 | 1.6727 | 1.1250 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 92.71 | 17.25 | 11544 | 6184 | 1.8667 | 1.1527 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 94.68 | 17.25 | 10684 | 6239 | 1.7124 | 1.1307 | MN20160310_N02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 94.68 | 17.25 | 11627 | 6239 | 1.8635 | 1.1520 | MN20160310_N02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 3.06 | 17.25 | 6 | 143 | 0.0419 | -0.2924 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 3.06 | 17.25 | 337 | 143 | 2.3531 | 1.6470 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 3.06 | 17.25 | 377 | 143 | 2.6324 | 1.7460 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 5.03 | 17.25 | 2 | 273 | 0.0073 | -0.4176 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 5.03 | 17.25 | 559 | 273 | 2.0449 | 1.3932 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 5.03 | 17.25 | 700 | 273 | 2.5608 | 1.5321 | MN20160310_N02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 7.01 | 17.25 | 8 | 389 | 0.0205 | -0.1571 | MN20160310_N02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 7.01 | 17.25 | 722 | 389 | 1.8537 | 1.2942 | MN20160310_N02 | E19 |